Search
Filter Results
Displaying 41–50 of 258 for “adeno-associated virus”
-
Apr 30, 2024
Leber Congenital Amaurosis Research Advances
Recent developments in research on Leber congenital amaurosis
-
Apr 30, 2024
Retinitis Pigmentosa Research Advances
Recent developments in research on retinitis pigmintosa.
-
Mar 26, 2024
Opus Reports Vision Improvements for Patients in LCA5 Gene Therapy Clinical Trial
The company plans to administer a higher dose of the emerging gene therapy to the next group of patients.
-
Feb 1, 2024
Ascidian to Launch Clinical Trial for Stargardt Disease RNA Editing Therapy
ACDN-01 is the only genetic medicine entering clinical development for Stargardt disease.
-
Sep 7, 2023
First Patient Dosed in LCA5 Gene Therapy Clinical Trial Launched by Opus Genetics
Opus was established by the RD Fund, the Foundation’s venture philanthropy arm
-
Aug 31, 2023
SparingVision Recruiting for Clinical Trial of Cone-Preserving Gene Therapy for RP
First cohort of patients has been dosed in Phase ½ clinical trial taking place in Pittsburgh and Paris
-
Jun 1, 2023
Coave Reports Encouraging Phase 1/2 Clinical Trial Results for PDE6B Gene Therapy
The company is expanding the trial to enroll younger patients with less advanced disease
-
Jan 3, 2023
Opus Genetics Acquires Rights to Gene Therapies for BEST1 and RP (RHO)
The company plans to seek clinical trial authorization for the BEST1 gene therapy during the second half of 2023
-
Dec 2, 2022
Opus Genetics to Launch Gene Therapy Clinical Trial for LCA5 Patients
The LCA5 gene therapy will be the first emerging Opus treatment to move into a human study
-
Nov 18, 2022
Editas Reports Results for 14 Participants in its Phase 1/2 CRISPR/Cas9 Clinical Trial for LCA10
The company is seeking a partner to move the LCA10 program forward